Prenatal Diagnostics-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Prenatal Diagnostics-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Prenatal Diagnostics industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Prenatal Diagnostics 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Prenatal Diagnostics worldwide and market share by regions, with company and product introduction, position in the Prenatal Diagnostics market
Market status and development trend of Prenatal Diagnostics by types and applications
Cost and profit status of Prenatal Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the global Prenatal Diagnostics market as:
Global Prenatal Diagnostics Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Prenatal Diagnostics Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Invasive
Non-invasive
Global Prenatal Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Others
Global Prenatal Diagnostics Market: Manufacturers Segment Analysis (Company and Product introduction, Prenatal Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Abbott Diabetes Care Inc (US)
Acon Laboratories Inc(US)
AgaMatrix Inc (US)
Alere Inc (US)
Animas Corporation (US)
Apex Biotechnology Corporation (Taiwan)
ARKRAY Inc (Japan)
Ascensia Diabetes Care Holdings AG (Switzerland)
A.Menarini Diagnostics Ltd (UK)
B. Braun Melsungen AG (Germany)
Becton, Dickinson and Company (US)
Bayer Healthcare Diabetes Care (US)
Beckman Coulter Inc (US)
Bio-Rad Laboratories (US)
BIONIME Corporation (Taiwan)
Diazyme Laboratories Inc (US)
Dexcom Inc(US)
EKF Diagnostics Holdings Plc (UK)
HemoCue(r) AB (Sweden)
Infopia Co Ltd(South Korea)
LifeScan Inc(US)
Medtronic MiniMed Inc(US)
Nova Biomedical Corporation (US)
PTS Diagnostics (US)
Roche Diagnostics (Switzerland)
Sanofi S.A. (France)
Sanwa Kagaku Kenkyusho Co Ltd(Japan)
Siemens Healthineers (Germany)
Taidoc Technology Corporation (Taiwan)
Terumo Corporation (Japan)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Prenatal Diagnostics-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Prenatal Diagnostics industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Prenatal Diagnostics 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Prenatal Diagnostics worldwide and market share by regions, with company and product introduction, position in the Prenatal Diagnostics market
Market status and development trend of Prenatal Diagnostics by types and applications
Cost and profit status of Prenatal Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the global Prenatal Diagnostics market as:
Global Prenatal Diagnostics Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Prenatal Diagnostics Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Invasive
Non-invasive
Global Prenatal Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Others
Global Prenatal Diagnostics Market: Manufacturers Segment Analysis (Company and Product introduction, Prenatal Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Abbott Diabetes Care Inc (US)
Acon Laboratories Inc(US)
AgaMatrix Inc (US)
Alere Inc (US)
Animas Corporation (US)
Apex Biotechnology Corporation (Taiwan)
ARKRAY Inc (Japan)
Ascensia Diabetes Care Holdings AG (Switzerland)
A.Menarini Diagnostics Ltd (UK)
B. Braun Melsungen AG (Germany)
Becton, Dickinson and Company (US)
Bayer Healthcare Diabetes Care (US)
Beckman Coulter Inc (US)
Bio-Rad Laboratories (US)
BIONIME Corporation (Taiwan)
Diazyme Laboratories Inc (US)
Dexcom Inc(US)
EKF Diagnostics Holdings Plc (UK)
HemoCue(r) AB (Sweden)
Infopia Co Ltd(South Korea)
LifeScan Inc(US)
Medtronic MiniMed Inc(US)
Nova Biomedical Corporation (US)
PTS Diagnostics (US)
Roche Diagnostics (Switzerland)
Sanofi S.A. (France)
Sanwa Kagaku Kenkyusho Co Ltd(Japan)
Siemens Healthineers (Germany)
Taidoc Technology Corporation (Taiwan)
Terumo Corporation (Japan)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PRENATAL DIAGNOSTICS
1.1 Definition of Prenatal Diagnostics in This Report
1.2 Commercial Types of Prenatal Diagnostics
1.2.1 Invasive
1.2.2 Non-invasive
1.3 Downstream Application of Prenatal Diagnostics
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Development History of Prenatal Diagnostics
1.5 Market Status and Trend of Prenatal Diagnostics 2013-2023
1.5.1 Global Prenatal Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Prenatal Diagnostics Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Prenatal Diagnostics 2013-2017
2.2 Sales Market of Prenatal Diagnostics by Regions
2.2.1 Sales Volume of Prenatal Diagnostics by Regions
2.2.2 Sales Value of Prenatal Diagnostics by Regions
2.3 Production Market of Prenatal Diagnostics by Regions
2.4 Global Market Forecast of Prenatal Diagnostics 2018-2023
2.4.1 Global Market Forecast of Prenatal Diagnostics 2018-2023
2.4.2 Market Forecast of Prenatal Diagnostics by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Prenatal Diagnostics by Types
3.2 Sales Value of Prenatal Diagnostics by Types
3.3 Market Forecast of Prenatal Diagnostics by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Prenatal Diagnostics by Downstream Industry
4.2 Global Market Forecast of Prenatal Diagnostics by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Prenatal Diagnostics Market Status by Countries
5.1.1 North America Prenatal Diagnostics Sales by Countries (2013-2017)
5.1.2 North America Prenatal Diagnostics Revenue by Countries (2013-2017)
5.1.3 United States Prenatal Diagnostics Market Status (2013-2017)
5.1.4 Canada Prenatal Diagnostics Market Status (2013-2017)
5.1.5 Mexico Prenatal Diagnostics Market Status (2013-2017)
5.2 North America Prenatal Diagnostics Market Status by Manufacturers
5.3 North America Prenatal Diagnostics Market Status by Type (2013-2017)
5.3.1 North America Prenatal Diagnostics Sales by Type (2013-2017)
5.3.2 North America Prenatal Diagnostics Revenue by Type (2013-2017)
5.4 North America Prenatal Diagnostics Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Prenatal Diagnostics Market Status by Countries
6.1.1 Europe Prenatal Diagnostics Sales by Countries (2013-2017)
6.1.2 Europe Prenatal Diagnostics Revenue by Countries (2013-2017)
6.1.3 Germany Prenatal Diagnostics Market Status (2013-2017)
6.1.4 UK Prenatal Diagnostics Market Status (2013-2017)
6.1.5 France Prenatal Diagnostics Market Status (2013-2017)
6.1.6 Italy Prenatal Diagnostics Market Status (2013-2017)
6.1.7 Russia Prenatal Diagnostics Market Status (2013-2017)
6.1.8 Spain Prenatal Diagnostics Market Status (2013-2017)
6.1.9 Benelux Prenatal Diagnostics Market Status (2013-2017)
6.2 Europe Prenatal Diagnostics Market Status by Manufacturers
6.3 Europe Prenatal Diagnostics Market Status by Type (2013-2017)
6.3.1 Europe Prenatal Diagnostics Sales by Type (2013-2017)
6.3.2 Europe Prenatal Diagnostics Revenue by Type (2013-2017)
6.4 Europe Prenatal Diagnostics Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Prenatal Diagnostics Market Status by Countries
7.1.1 Asia Pacific Prenatal Diagnostics Sales by Countries (2013-2017)
7.1.2 Asia Pacific Prenatal Diagnostics Revenue by Countries (2013-2017)
7.1.3 China Prenatal Diagnostics Market Status (2013-2017)
7.1.4 Japan Prenatal Diagnostics Market Status (2013-2017)
7.1.5 India Prenatal Diagnostics Market Status (2013-2017)
7.1.6 Southeast Asia Prenatal Diagnostics Market Status (2013-2017)
7.1.7 Australia Prenatal Diagnostics Market Status (2013-2017)
7.2 Asia Pacific Prenatal Diagnostics Market Status by Manufacturers
7.3 Asia Pacific Prenatal Diagnostics Market Status by Type (2013-2017)
7.3.1 Asia Pacific Prenatal Diagnostics Sales by Type (2013-2017)
7.3.2 Asia Pacific Prenatal Diagnostics Revenue by Type (2013-2017)
7.4 Asia Pacific Prenatal Diagnostics Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Prenatal Diagnostics Market Status by Countries
8.1.1 Latin America Prenatal Diagnostics Sales by Countries (2013-2017)
8.1.2 Latin America Prenatal Diagnostics Revenue by Countries (2013-2017)
8.1.3 Brazil Prenatal Diagnostics Market Status (2013-2017)
8.1.4 Argentina Prenatal Diagnostics Market Status (2013-2017)
8.1.5 Colombia Prenatal Diagnostics Market Status (2013-2017)
8.2 Latin America Prenatal Diagnostics Market Status by Manufacturers
8.3 Latin America Prenatal Diagnostics Market Status by Type (2013-2017)
8.3.1 Latin America Prenatal Diagnostics Sales by Type (2013-2017)
8.3.2 Latin America Prenatal Diagnostics Revenue by Type (2013-2017)
8.4 Latin America Prenatal Diagnostics Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Prenatal Diagnostics Market Status by Countries
9.1.1 Middle East and Africa Prenatal Diagnostics Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Prenatal Diagnostics Revenue by Countries (2013-2017)
9.1.3 Middle East Prenatal Diagnostics Market Status (2013-2017)
9.1.4 Africa Prenatal Diagnostics Market Status (2013-2017)
9.2 Middle East and Africa Prenatal Diagnostics Market Status by Manufacturers
9.3 Middle East and Africa Prenatal Diagnostics Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Prenatal Diagnostics Sales by Type (2013-2017)
9.3.2 Middle East and Africa Prenatal Diagnostics Revenue by Type (2013-2017)
9.4 Middle East and Africa Prenatal Diagnostics Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PRENATAL DIAGNOSTICS
10.1 Global Economy Situation and Trend Overview
10.2 Prenatal Diagnostics Downstream Industry Situation and Trend Overview
CHAPTER 11 PRENATAL DIAGNOSTICS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Prenatal Diagnostics by Major Manufacturers
11.2 Production Value of Prenatal Diagnostics by Major Manufacturers
11.3 Basic Information of Prenatal Diagnostics by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Prenatal Diagnostics Major Manufacturer
11.3.2 Employees and Revenue Level of Prenatal Diagnostics Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PRENATAL DIAGNOSTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Abbott Diabetes Care Inc (US)
12.1.1 Company profile
12.1.2 Representative Prenatal Diagnostics Product
12.1.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Diabetes Care Inc (US)
12.2 Acon Laboratories Inc(US)
12.2.1 Company profile
12.2.2 Representative Prenatal Diagnostics Product
12.2.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Acon Laboratories Inc(US)
12.3 AgaMatrix Inc (US)
12.3.1 Company profile
12.3.2 Representative Prenatal Diagnostics Product
12.3.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of AgaMatrix Inc (US)
12.4 Alere Inc (US)
12.4.1 Company profile
12.4.2 Representative Prenatal Diagnostics Product
12.4.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Alere Inc (US)
12.5 Animas Corporation (US)
12.5.1 Company profile
12.5.2 Representative Prenatal Diagnostics Product
12.5.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Animas Corporation (US)
12.6 Apex Biotechnology Corporation (Taiwan)
12.6.1 Company profile
12.6.2 Representative Prenatal Diagnostics Product
12.6.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Apex Biotechnology Corporation (Taiwan)
12.7 ARKRAY Inc (Japan)
12.7.1 Company profile
12.7.2 Representative Prenatal Diagnostics Product
12.7.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of ARKRAY Inc (Japan)
12.8 Ascensia Diabetes Care Holdings AG (Switzerland)
12.8.1 Company profile
12.8.2 Representative Prenatal Diagnostics Product
12.8.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Ascensia Diabetes Care Holdings AG (Switzerland)
12.9 A.Menarini Diagnostics Ltd (UK)
12.9.1 Company profile
12.9.2 Representative Prenatal Diagnostics Product
12.9.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of A.Menarini Diagnostics Ltd (UK)
12.10 B. Braun Melsungen AG (Germany)
12.10.1 Company profile
12.10.2 Representative Prenatal Diagnostics Product
12.10.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of B. Braun Melsungen AG (Germany)
12.11 Becton, Dickinson and Company (US)
12.11.1 Company profile
12.11.2 Representative Prenatal Diagnostics Product
12.11.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Becton, Dickinson and Company (US)
12.12 Bayer Healthcare Diabetes Care (US)
12.12.1 Company profile
12.12.2 Representative Prenatal Diagnostics Product
12.12.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Bayer Healthcare Diabetes Care (US)
12.13 Beckman Coulter Inc (US)
12.13.1 Company profile
12.13.2 Representative Prenatal Diagnostics Product
12.13.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Beckman Coulter Inc (US)
12.14 Bio-Rad Laboratories (US)
12.14.1 Company profile
12.14.2 Representative Prenatal Diagnostics Product
12.14.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories (US)
12.15 BIONIME Corporation (Taiwan)
12.15.1 Company profile
12.15.2 Representative Prenatal Diagnostics Product
12.15.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of BIONIME Corporation (Taiwan)
12.16 Diazyme Laboratories Inc (US)
12.17 Dexcom Inc(US)
12.18 EKF Diagnostics Holdings Plc (UK)
12.19 HemoCue(r) AB (Sweden)
12.20 Infopia Co Ltd(South Korea)
12.21 LifeScan Inc(US)
12.22 Medtronic MiniMed Inc(US)
12.23 Nova Biomedical Corporation (US)
12.24 PTS Diagnostics (US)
12.25 Roche Diagnostics (Switzerland)
12.26 Sanofi S.A. (France)
12.27 Sanwa Kagaku Kenkyusho Co Ltd(Japan)
12.28 Siemens Healthineers (Germany)
12.29 Taidoc Technology Corporation (Taiwan)
12.30 Terumo Corporation (Japan)
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PRENATAL DIAGNOSTICS
13.1 Industry Chain of Prenatal Diagnostics
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PRENATAL DIAGNOSTICS
14.1 Cost Structure Analysis of Prenatal Diagnostics
14.2 Raw Materials Cost Analysis of Prenatal Diagnostics
14.3 Labor Cost Analysis of Prenatal Diagnostics
14.4 Manufacturing Expenses Analysis of Prenatal Diagnostics
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Prenatal Diagnostics in This Report
1.2 Commercial Types of Prenatal Diagnostics
1.2.1 Invasive
1.2.2 Non-invasive
1.3 Downstream Application of Prenatal Diagnostics
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Development History of Prenatal Diagnostics
1.5 Market Status and Trend of Prenatal Diagnostics 2013-2023
1.5.1 Global Prenatal Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Prenatal Diagnostics Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Prenatal Diagnostics 2013-2017
2.2 Sales Market of Prenatal Diagnostics by Regions
2.2.1 Sales Volume of Prenatal Diagnostics by Regions
2.2.2 Sales Value of Prenatal Diagnostics by Regions
2.3 Production Market of Prenatal Diagnostics by Regions
2.4 Global Market Forecast of Prenatal Diagnostics 2018-2023
2.4.1 Global Market Forecast of Prenatal Diagnostics 2018-2023
2.4.2 Market Forecast of Prenatal Diagnostics by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Prenatal Diagnostics by Types
3.2 Sales Value of Prenatal Diagnostics by Types
3.3 Market Forecast of Prenatal Diagnostics by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Prenatal Diagnostics by Downstream Industry
4.2 Global Market Forecast of Prenatal Diagnostics by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Prenatal Diagnostics Market Status by Countries
5.1.1 North America Prenatal Diagnostics Sales by Countries (2013-2017)
5.1.2 North America Prenatal Diagnostics Revenue by Countries (2013-2017)
5.1.3 United States Prenatal Diagnostics Market Status (2013-2017)
5.1.4 Canada Prenatal Diagnostics Market Status (2013-2017)
5.1.5 Mexico Prenatal Diagnostics Market Status (2013-2017)
5.2 North America Prenatal Diagnostics Market Status by Manufacturers
5.3 North America Prenatal Diagnostics Market Status by Type (2013-2017)
5.3.1 North America Prenatal Diagnostics Sales by Type (2013-2017)
5.3.2 North America Prenatal Diagnostics Revenue by Type (2013-2017)
5.4 North America Prenatal Diagnostics Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Prenatal Diagnostics Market Status by Countries
6.1.1 Europe Prenatal Diagnostics Sales by Countries (2013-2017)
6.1.2 Europe Prenatal Diagnostics Revenue by Countries (2013-2017)
6.1.3 Germany Prenatal Diagnostics Market Status (2013-2017)
6.1.4 UK Prenatal Diagnostics Market Status (2013-2017)
6.1.5 France Prenatal Diagnostics Market Status (2013-2017)
6.1.6 Italy Prenatal Diagnostics Market Status (2013-2017)
6.1.7 Russia Prenatal Diagnostics Market Status (2013-2017)
6.1.8 Spain Prenatal Diagnostics Market Status (2013-2017)
6.1.9 Benelux Prenatal Diagnostics Market Status (2013-2017)
6.2 Europe Prenatal Diagnostics Market Status by Manufacturers
6.3 Europe Prenatal Diagnostics Market Status by Type (2013-2017)
6.3.1 Europe Prenatal Diagnostics Sales by Type (2013-2017)
6.3.2 Europe Prenatal Diagnostics Revenue by Type (2013-2017)
6.4 Europe Prenatal Diagnostics Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Prenatal Diagnostics Market Status by Countries
7.1.1 Asia Pacific Prenatal Diagnostics Sales by Countries (2013-2017)
7.1.2 Asia Pacific Prenatal Diagnostics Revenue by Countries (2013-2017)
7.1.3 China Prenatal Diagnostics Market Status (2013-2017)
7.1.4 Japan Prenatal Diagnostics Market Status (2013-2017)
7.1.5 India Prenatal Diagnostics Market Status (2013-2017)
7.1.6 Southeast Asia Prenatal Diagnostics Market Status (2013-2017)
7.1.7 Australia Prenatal Diagnostics Market Status (2013-2017)
7.2 Asia Pacific Prenatal Diagnostics Market Status by Manufacturers
7.3 Asia Pacific Prenatal Diagnostics Market Status by Type (2013-2017)
7.3.1 Asia Pacific Prenatal Diagnostics Sales by Type (2013-2017)
7.3.2 Asia Pacific Prenatal Diagnostics Revenue by Type (2013-2017)
7.4 Asia Pacific Prenatal Diagnostics Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Prenatal Diagnostics Market Status by Countries
8.1.1 Latin America Prenatal Diagnostics Sales by Countries (2013-2017)
8.1.2 Latin America Prenatal Diagnostics Revenue by Countries (2013-2017)
8.1.3 Brazil Prenatal Diagnostics Market Status (2013-2017)
8.1.4 Argentina Prenatal Diagnostics Market Status (2013-2017)
8.1.5 Colombia Prenatal Diagnostics Market Status (2013-2017)
8.2 Latin America Prenatal Diagnostics Market Status by Manufacturers
8.3 Latin America Prenatal Diagnostics Market Status by Type (2013-2017)
8.3.1 Latin America Prenatal Diagnostics Sales by Type (2013-2017)
8.3.2 Latin America Prenatal Diagnostics Revenue by Type (2013-2017)
8.4 Latin America Prenatal Diagnostics Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Prenatal Diagnostics Market Status by Countries
9.1.1 Middle East and Africa Prenatal Diagnostics Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Prenatal Diagnostics Revenue by Countries (2013-2017)
9.1.3 Middle East Prenatal Diagnostics Market Status (2013-2017)
9.1.4 Africa Prenatal Diagnostics Market Status (2013-2017)
9.2 Middle East and Africa Prenatal Diagnostics Market Status by Manufacturers
9.3 Middle East and Africa Prenatal Diagnostics Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Prenatal Diagnostics Sales by Type (2013-2017)
9.3.2 Middle East and Africa Prenatal Diagnostics Revenue by Type (2013-2017)
9.4 Middle East and Africa Prenatal Diagnostics Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PRENATAL DIAGNOSTICS
10.1 Global Economy Situation and Trend Overview
10.2 Prenatal Diagnostics Downstream Industry Situation and Trend Overview
CHAPTER 11 PRENATAL DIAGNOSTICS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Prenatal Diagnostics by Major Manufacturers
11.2 Production Value of Prenatal Diagnostics by Major Manufacturers
11.3 Basic Information of Prenatal Diagnostics by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Prenatal Diagnostics Major Manufacturer
11.3.2 Employees and Revenue Level of Prenatal Diagnostics Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PRENATAL DIAGNOSTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Abbott Diabetes Care Inc (US)
12.1.1 Company profile
12.1.2 Representative Prenatal Diagnostics Product
12.1.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Diabetes Care Inc (US)
12.2 Acon Laboratories Inc(US)
12.2.1 Company profile
12.2.2 Representative Prenatal Diagnostics Product
12.2.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Acon Laboratories Inc(US)
12.3 AgaMatrix Inc (US)
12.3.1 Company profile
12.3.2 Representative Prenatal Diagnostics Product
12.3.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of AgaMatrix Inc (US)
12.4 Alere Inc (US)
12.4.1 Company profile
12.4.2 Representative Prenatal Diagnostics Product
12.4.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Alere Inc (US)
12.5 Animas Corporation (US)
12.5.1 Company profile
12.5.2 Representative Prenatal Diagnostics Product
12.5.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Animas Corporation (US)
12.6 Apex Biotechnology Corporation (Taiwan)
12.6.1 Company profile
12.6.2 Representative Prenatal Diagnostics Product
12.6.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Apex Biotechnology Corporation (Taiwan)
12.7 ARKRAY Inc (Japan)
12.7.1 Company profile
12.7.2 Representative Prenatal Diagnostics Product
12.7.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of ARKRAY Inc (Japan)
12.8 Ascensia Diabetes Care Holdings AG (Switzerland)
12.8.1 Company profile
12.8.2 Representative Prenatal Diagnostics Product
12.8.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Ascensia Diabetes Care Holdings AG (Switzerland)
12.9 A.Menarini Diagnostics Ltd (UK)
12.9.1 Company profile
12.9.2 Representative Prenatal Diagnostics Product
12.9.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of A.Menarini Diagnostics Ltd (UK)
12.10 B. Braun Melsungen AG (Germany)
12.10.1 Company profile
12.10.2 Representative Prenatal Diagnostics Product
12.10.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of B. Braun Melsungen AG (Germany)
12.11 Becton, Dickinson and Company (US)
12.11.1 Company profile
12.11.2 Representative Prenatal Diagnostics Product
12.11.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Becton, Dickinson and Company (US)
12.12 Bayer Healthcare Diabetes Care (US)
12.12.1 Company profile
12.12.2 Representative Prenatal Diagnostics Product
12.12.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Bayer Healthcare Diabetes Care (US)
12.13 Beckman Coulter Inc (US)
12.13.1 Company profile
12.13.2 Representative Prenatal Diagnostics Product
12.13.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Beckman Coulter Inc (US)
12.14 Bio-Rad Laboratories (US)
12.14.1 Company profile
12.14.2 Representative Prenatal Diagnostics Product
12.14.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories (US)
12.15 BIONIME Corporation (Taiwan)
12.15.1 Company profile
12.15.2 Representative Prenatal Diagnostics Product
12.15.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of BIONIME Corporation (Taiwan)
12.16 Diazyme Laboratories Inc (US)
12.17 Dexcom Inc(US)
12.18 EKF Diagnostics Holdings Plc (UK)
12.19 HemoCue(r) AB (Sweden)
12.20 Infopia Co Ltd(South Korea)
12.21 LifeScan Inc(US)
12.22 Medtronic MiniMed Inc(US)
12.23 Nova Biomedical Corporation (US)
12.24 PTS Diagnostics (US)
12.25 Roche Diagnostics (Switzerland)
12.26 Sanofi S.A. (France)
12.27 Sanwa Kagaku Kenkyusho Co Ltd(Japan)
12.28 Siemens Healthineers (Germany)
12.29 Taidoc Technology Corporation (Taiwan)
12.30 Terumo Corporation (Japan)
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PRENATAL DIAGNOSTICS
13.1 Industry Chain of Prenatal Diagnostics
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PRENATAL DIAGNOSTICS
14.1 Cost Structure Analysis of Prenatal Diagnostics
14.2 Raw Materials Cost Analysis of Prenatal Diagnostics
14.3 Labor Cost Analysis of Prenatal Diagnostics
14.4 Manufacturing Expenses Analysis of Prenatal Diagnostics
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
